Flow cytometric assay detecting cytotoxicity against human endogenous retrovirus antigens expressed on cultured multiple sclerosis cells

Clinical and Experimental Immunology

Volumn 173, Issue 3, 2013, Pages 398-410

  Moller Larsen A ^a   Brudek, T ^c   Petersen, T ^b   Petersen, E L ^a   Aagaard, M ^a   Hansen, D T ^a   Christensen, T ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

Author keywords

ADCC; CD107a; Flow cytometry; HERV; NK cells

Indexed keywords

CD20 ANTIBODY; CD3 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; EPITOPE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; RITUXIMAB; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LINEAGE; CELL POPULATION; CONTROLLED STUDY; EFFECTOR CELL; ENDOGENOUS RETROVIRUS; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOGENICITY; LYMPHOBLASTOID CELL LINE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TARGET CELL;

ADCC; CD107A; FLOW CYTOMETRY; HERV; NK CELLS;

ADULT; ANTIBODIES; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; ENDOGENOUS RETROVIRUSES; FEMALE; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; T-LYMPHOCYTES, CYTOTOXIC; YOUNG ADULT;

EID: 84881523181     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12133     Document Type: Article

References (40)

1. Brudek T, Christensen T, Aagaard L, Petersen T, Hansen HJ, Møller-Larsen A. B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity. Retrovirology 2009; 6:104.
2. Bottley G, Cook GP, Blair GE. A flow cytometric assay for analysis of natural-killer cell-mediated cytolysis of adenovirus-transformed cells. Methods Mol Med 2007; 131:221-230.
3. Zimmermann SY, Esser R, Rohrbach E, Klingebiel T, Koehl U. A novel four-colour flow cytometric assay to determine natural killer cell or T-cell-mediated cellular cytotoxicity against leukaemic cells in peripheral or bone marrow specimens containing greater than 20% of normal cells. J Immunol Methods 2005; 296:63-76.
4. Cholujová D, Jakubíková J, Kubes M etal. Comparative study of four fluorescent probes for evaluation of natural killer cell cytotoxicity assays. Immunobiology 2008; 213:629-640.
5. Bryceson YT, Fauriat C, Nunes JM etal. Functional analysis of human NK cells by flow cytometry. Methods Mol Biol 2010; 612:335-352.
6. Uhrberg M. The CD107 mobilization assay: viable isolation and immunotherapeutic potential of tumor-cytolytic NK cells. Leukemia 2005; 19:707-709.
7. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004; 294:15-22.
8. Munch M, Møller-Larsen A, Christensen T, Morling N, Hansen HJ, Haahr S. B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus. Mult Scler 1995; 1:78-81.
9. Christensen T, Jensen AW, Munch M etal. Characterization of retroviruses from patients with multiple sclerosis. Acta Neurol Scand 1997; S169:49-58.
10. de Parseval N, Casella J, Gressin L, Heidmann T. Characterization of the three HERV-H proviruses with an open envelope reading frame encompassing the immunosuppressive domain and evolutionary history in primates. Virology 2001; 279:558-569.
11. Mallet F, Bouton O, Prudhomme S etal. The endogenous retroviral locus ERVWE1 is a bona fide gene involved in hominoid placental physiology. Proc Natl Acad Sci USA 2004; 101:1731-1736.
12. Poli A, Michel T, Thérésine M, Andrès E, Hentges F, Zimmer J. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 2009; 126:458-465.
13. Johnson TA, Evans BL, Durafourt BA etal. Reduction of the peripheral blood CD56(bright) NK lymphocyte subset in FTY720-treated multiple sclerosis patients. J Immunol 2011; 187:570-579.
14. Neumann H, Medana IM, Bauer J, Lassmann H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci 2002; 25:313-319.
15. Friese MA, Fugger L. Pathogenic CD8(+) T cells in multiple sclerosis. Ann Neurol 2009; 66:132-141.
16. Sobottka B, Harrer MD, Ziegler U etal. Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss. Am J Pathol 2009; 175:1160-1166.
17. Kasper LH, Shoemaker J. Multiple sclerosis immunology: the healthy immune system vs the MS immune system. Neurology 2010; 74 (Suppl. 1):S 2-8.
18. Flodström-Tullberg M, Bryceson YT, Shi FD, Höglund P, Ljunggren HG. Natural killer cells in human autoimmunity. Curr Opin Immunol 2009; 21:634-640.
19. Christensen T. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev Med Virol 2005; 15:179-211.
20. Jolivet-Reynaud C, Perron H, Ferrante P, Becquart L, Dalbon P, Mandrand B. Specificities of multiple sclerosis cerebrospinal fluid and serum antibodies against mimotopes. Clin Immunol 1999; 93:283-293.
21. Reiber H, Ungefehr S, Jacobi C. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 1998; 4:111-117.
22. Franciotta D, Salvetti M, Lolli F, Serafini B, Aloisi F. B cells and multiple sclerosis. Lancet Neurol 2008; 7:852-858.
23. Cepok S, Rosche B, Grummel V etal. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 2005; 128:1667-1676.
24. Stüve O, Cepok S, Elias B etal. Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis. Arch Neurol 2005; 62:1620-1623.
25. Hafler DA, Slavik JM, Anderson DE, O'Connor KC, De Jager P, Baecher-Allan C. Multiple sclerosis. Immunol Rev 2005; 204:208-3.
26. Motzer SA, Tsuji J, Hertig V, Johnston SK, Scanlan J. Natural killer cell cytotoxicity: a methods analysis of 51chromium release versus flow cytometry. Biol Res Nurs 2003; 5:142-152.
27. Laska M, Brudek T, Nissen K etal. Expression of HERV-Fc1, a human endogenous retrovirus, is increased in patients with active multiple sclerosis. J Virol 2012; 86:3713-3722.
28. Dorweiler IJ, Ruone SJ, Wang H, Burry RW, Mansky LM. Role of the human T-cell leukemia virus type 1 PTAP motif in Gag targeting and particle release. J Virol 2006; 80:3634-3643.
29. Perron H, Germi R, Bernard C etal. Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult Scler 2012; 18:1721-1736.
30. Antony JM, Izad M, Bar-Or A etal. Quantitative analysis of human endogenous retrovirus-W env in neuroinflammatory diseases. AIDS Res Hum Retroviruses 2006; 22:1253-1259.
31. Serra C, Sotgiu S, Mameli G, Pugliatti M, Rosati G, Dolei A. Multiple sclerosis and multiple sclerosis-associated retrovirus in Sardinia. Neurol Sci 2001; 22:171-173.
32. Fischer L, Penack O, Gentilini C etal. The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells. Exp Hematol 2006; 34:753-759.
33. Chung AW, Rollman E, Center RJ, Kent SJ, Stratov I. Rapid degranulation of NK cells following activation by HIV-specific antibodies. J Immunol 2009; 182:1202-1210.
34. Mittendorf EA, Storrer CE, Shriver CD, Ponniah S, Peoples GE. Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8+ cells recognizing HER2/neu vaccine peptides. Breast Cancer Res Treat 2005; 92:85-93.
35. Shacklett BL. Beyond 51Cr release: new methods for assessing HIV-1-specific CD8+ T cell responses in peripheral blood and mucosal tissues. Clin Exp Immunol 2002; 130:172-182.
36. Christensen T, Petersen T, Thiel S, Brudek T, Ellermann-Eriksen S, Møller-Larsen A. Gene-environment interactions in multiple sclerosis: innate and adaptive immune responses to human endogenous retrovirus and herpesvirus antigens and the lectin complement activation pathway. J Neuroimmunol 2007; 183:175-188.
37. Betts MR, Brenchley JM, Price DA etal. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003; 281:65-78.
38. Chen Z, Freedman MS. Correlation of specialized CD16(+) gammadelta T cells with disease course and severity in multiple sclerosis. J Neuroimmunol 2008; 194:147-152.
39. Chen Z, Freedman MS. γδ T cells and multiple sclerosis: friends, foes, or both? Autoimmun Rev 2011; 10:364-367.
40. Gandhi R, Laroni A, Weiner HL. Role of the innate immune system in the pathogenesis of multiple sclerosis. J Neuroimmunol 2010; 221:7-14.